Lymphomas: Complexity, not chaos

Current Opinion in Oncology

Volumn 12, Issue 5, 2000, Pages 379-382

  Longo, Dan L ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CELL SURFACE PROTEIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOLINIC ACID; GLYCOPROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; DISEASE CLASSIFICATION; FOLLICULAR LYMPHOMA; HUMAN; IMMUNOGLOBULIN GENE; LYMPHATIC SYSTEM TUMOR; LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THYMOMA;

ANIMALS; HUMANS; LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 0034457345     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200009000-00001     Document Type: Review

References (6)

1. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997
2. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma
3. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by gallium-67 scan in 50 patients
4. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
5. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
6. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling